Home PageWhat is EIPH ?Possible TreatmentVet ReportsAbout Dr. KhouriE-mail Dr. Khouri
Info for vets

Dog Paralysis

Also in Arabic


Possible Treatment of EIPH


A novel compound, developed by Dr. Khouri, is a Human Leukocyte Elastase/Protease Inhibitor, seems to help reduce or stop bleeding from the lungs in race horses. Exercise Induced Pulmonary Hemorrhage is well known condition in the horse racing community. Almost all horses, racing or not, may develop in microscopic or large lung bleeding. According to several vets, there is no definite treatment for this devastating ailment.

It seems that during hard running the blood pressure in the lungs becomes so high, blood leaks from the small blood vessels ending up in the airways, throat and nostrils. The pulmonary blood pressure rises from 20 mm of mercury to 80 within few minutes. The reason for the bleeding is not well known. It is possible that the tiny blood vessel walls, made mostly of elastin, rupture leading to leakage of blood.

The compound was tested by few vets on twenty racehorses recognized as “bleeders” or “heavy bleeders”. Eighteen stopped bleeding, one had minimal bleeding by endoscopy and one horse, which was given one dose only, did not respond. Each horse was given via injection or orally for three or four days before racing*. Some horses looked calmer and the skin also looked better at the end of the race. No side effects were noted in any of the horses and the compound passed drug testing. This looks like a 90% response.

How does the compound work? Elastase is an enzyme that destroys elastin and it found in every tissue in the body. When any tissue is damaged for any reason, collagen and elastin are sent to the area; elastase destroys elastin and collagen develops into a scar. The compound inhibits the elastase (and protease enzymes), thus preventing scar formation and helping the tissue to reconstruct itself.

In the lung capillaries, it is possible that the compound may be strengthening the elastin polypeptide chains which makes more stretchy and/or harder to break due to high pulmonary blood pressure.
This US patented compound is in infancy and needs to be tested on horse models in a lab that has the facilities that perform those specific tests.

If a vet is interested in treating horses with EIPH, please email Dr. Khouri. After signing a confidentiality agreement and agreeing to send reports by fax or email, he or she will receive a vial with instructions to treat TWO horses at no charge. The compound is never sold.


*According to vets testing most horses established that only two doses given 48 and 24 hours before racing stopped bleeding.

 

 
Copyright © Dr. Charles Khouri 2006